SCHEMBL8304791

SCHEMBL8304791

CC(=NOCCOc1ccc(CC2SC(=O)N(C(c3ccccc3)(c3ccccc3)c3ccccc3)C2=O)cc1)c1ccc(N(C)S(=O)(=O)c2ccc(C)cc2)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.47
RXRA P19793 2/20 0.32
RARG P13631 1/20 0.32
NPC1 O15118 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 2/20 0.32
KMT2A Q03164 3/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
MEN1 O00255 2/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
MAPK1 P28482 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PTGES O14684 1/20 0.31
ALOX5 P09917 1/20 0.31
CNR2 P34972 1/20 0.31
RXRB P28702 1/20 0.31
RXRG P48443 1/20 0.31
LMNA P02545 1/20 0.30
TRPM8 Q7Z2W7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8387697 1.00 PPARG (0.47) PPARGRXRARARGNPC1KDM4E
SCHEMBL8308499 0.86 PPARG (0.45) PPARGNPC1KDM4EMAPTKMT2A
SCHEMBL8308501 0.86 PPARG (0.45) PPARGNPC1KDM4EMAPTKMT2A
SCHEMBL8309782 0.84 PPARG (0.51) PPARGKDM4EMAPTKMT2AMEN1
SCHEMBL8309781 0.84 PPARG (0.51) PPARGKDM4EMAPTKMT2AMEN1
SCHEMBL8304309 0.84 PPARG (0.52) PPARGRXRARARGMEN1
SCHEMBL8304307 0.84 PPARG (0.52) PPARGRXRARARGMEN1
SCHEMBL8309649 0.83 PPARG (0.48) PPARGRXRARARGNPC1MAPT
SCHEMBL8309646 0.83 PPARG (0.48) PPARGRXRARARGNPC1MAPT
SCHEMBL8387956 0.83 PPARG (0.62) PPARGRXRARARGMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed